ACPL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.108240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.737600E-02
Normal-vs-Stage2
1.377820E-01
Normal-vs-Stage3
3.731800E-02
Normal-vs-Stage4
5.489600E-01
Stage1-vs-Stage2
3.671200E-01
Stage1-vs-Stage3
4.893600E-01
Stage1-vs-Stage4
2.232600E-01
Stage2-vs-Stage3
1.765240E-01
Stage2-vs-Stage4
4.677000E-01
Stage3-vs-Stage4
1.518440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.406100E-02
Normal-vs-AfricanAmerican
5.693400E-01
Normal-vs-Asian
1.435990E-01
Caucasian-vs-AfricanAmerican
2.443600E-01
Caucasian-vs-Asian
9.139600E-01
AfricanAmerican-vs-Asian
3.654800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.648640E-01
Normal-vs-Female
5.534400E-02
Male-vs-Female
9.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.207200E-01
Normal-vs-Age(41-60Yrs)
1.935770E-01
Normal-vs-Age(61-80Yrs)
1.166410E-01
Normal-vs-Age(81-100Yrs)
1.957180E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.177760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.048400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.042400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.777900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.398400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.906300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.141700E-02
Normal-vs-Daily Drinker
1.203980E-02
Normal-vs-Weekly Drinker
2.995700E-02
Normal-vs-Occasional Drinker
2.593200E-01
Normal-vs-Social Drinker
1.690770E-01
Non Drinker-vs-Daily Drinker
3.206000E-01
Non Drinker-vs-Weekly Drinker
7.307600E-01
Non Drinker-vs-Occasional Drinker
4.181400E-01
Non Drinker-vs-Social Drinker
6.417400E-01
Daily Drinker-vs-Weekly Drinker
1.916640E-01
Daily Drinker-vs-Occasional Drinker
1.282450E-01
Daily Drinker-vs-Social Drinker
2.179800E-01
Weekly Drinker-vs-Occasional Drinker
6.347600E-01
Weekly Drinker-vs-Social Drinker
8.794800E-01
Occasional Drinker-vs-Social Drinker
7.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.042000E-01
Normal-vs-Grade 2
5.796400E-02
Normal-vs-Grade 3
1.141170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.441700E-03
Grade 1-vs-Grade 3
4.885700E-02
Grade 1-vs-Grade 4
4.042000E-01
Grade 2-vs-Grade 3
7.628800E-01
Grade 2-vs-Grade 4
5.796400E-02
Grade 3-vs-Grade 4
1.141170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.107900E-02
Normal-vs-NonDiabetic
8.529600E-02
Diabetic-vs-NonDiabetic
4.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.259990E-01
Normal-vs-NoPancreatitis
9.006000E-02
Pancreatitis-vs-NoPancreatitis
8.800200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.683700E-02
Normal-vs-N1
1.567800E-01
N0-vs-N1
6.474300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.654200E-01
Normal-vs-TP53-NonMutant
7.970400E-02
TP53-Mutant-vs-TP53-NonMutant
2.306000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
